BILL ANALYSIS                                                                                                                                                                                                    




                   Senate Appropriations Committee Fiscal Summary
                           Senator Christine Kehoe, Chair

                                           1063 (Cox)
          
          Hearing Date:  5/27/2010        Amended: 5/24/2010
          Consultant: Katie Johnson       Policy Vote: Health 9-0
          _________________________________________________________________ 
          ____
          BILL SUMMARY:  SB 1063 would require the Managed Risk Medical  
          Insurance Board (MRMIB) to structure copayments for prescription  
          drugs and emergency services for the Healthy Families Program  
          (Healthy Families) at specified minimum ratios.
          _________________________________________________________________ 
          ____
                            Fiscal Impact (in thousands)

           Major Provisions         2010-11      2011-12       2012-13     Fund
                                                                  
          Future potential cost    potentially in the millions of  
          dollars*General/**
          savings due to lower                                   Federal
          net cost and decreased
          utilization of services for
          above 150 percent FPL

          Future potential ED             unknown                General/
          and inpatient costs                                    Federal

          *See staff comments.     
          **Costs are reimbursed 35 percent General Fund and 65 percent  
          Federal Funds
          _________________________________________________________________ 
          ____
          STAFF COMMENTS: SUSPENSE FILE. 

          This bill would require: a) copayments for emergency health  
          services to be set at a level that is at least 150 percent of  
          the highest copayment charged for nonpreventive health care  
          services, except when the person is hospitalized; (b) copayments  
          for brand name prescription drugs to be set at a level that is  
          at least 150 percent of the highest copayment charged for an  
          equivalent generic prescription drug, except where no equivalent  
          generic drug is available. 

          Potential Future Cost Savings and Potential Costs Related to  










          Underutilization
          
          While this bill would reduce MRMIB's flexibility to utilize  
          regulations to adjust subscriber cost-sharing requirements  
          through regulation, the bill's provisions would institute a  
          statutory requirement intended to manage future utilization  
          rates and minimize program costs.  

          Brand name drugs are generally more expensive to provide than  
          equivalent generic drugs and care provided in an outpatient  
          setting is generally less expensive than that provided in an  
          emergency room. To the extent that this bill maintains those  
          incentives and that the subscriber chooses to access more cost  
          effective alternative, there could 


          Page 2
          SB 1063 (Cox)

          be savings realized in the form of decreased utilization of  
          services and a lower net cost of a prescription or a service.  
          However, some of these savings may be offset by increased  
          emergency department (ED) and inpatient costs due to the  
          decreased 
          utilization and underutilization of physician services when  
          necessary. It is unknown whether or not these ED and inpatient  
          costs would negate the cost savings.

          An example provided by Mercer Consulting in an actuarial  
          analysis presented to MRMIB at its April 21, 2010, board meeting  
          estimated the Healthy Families cost savings if the copayment for  
          physician services was increased from $10 to $15 per visit. Due  
          to decreased physician service utilization and to unit cost,  
          Healthy Families could realize $25 million in total funds  
          savings, of which $8.8 million would be General Fund. Mercer  
          notes, however, that there would likely be an increase to  
          inpatient and ED costs and that, although it would be difficult  
          to quantify, it could offset some of the savings achieved by the  
          increased physician services copayment. For individuals who  
          utilize more than the average number of services, the copayments  
          could become unaffordable and they may forgo necessary services  
          until it is absolutely necessary, resulting in higher treatment  
          costs for more serious conditions.

          Current HFP Copayments
          










          MRMIB's current copayment levels are set by the board through  
          regulation. They are:

             A)   For subscribers with family incomes 101-150 percent  
               Federal Poverty Level (FPL), copayments for all services,  
               for which one is required, are currently $5, the legal  
               maximum.

             B)   For subscribers with family incomes above 150 percent  
               FPL, for generic and brand name prescription drugs are $10  
               and $15, respectively, and for non-preventive and emergency  
               health services are $10 and $15, respectively. No copayment  
               is required for generic or brand name contraceptive drugs.

          Pursuant to federal regulations, copayments may not exceed $5  
          for Healthy Families subscribers with family incomes 101-150  
          percent FPL. The May 24, 2010, amendments would exempt this  
          group.

          If MRMIB were to alter copayments in the future through  
          regulation, it would be important to balance program savings and  
          the potential for underutilization of services and indirect ED,  
          inpatient costs, and state-funded program costs. This bill would  
          limit the flexibility of the board to adjust copayment levels in  
          the future through regulations.